Results 191 to 200 of about 55,815 (216)

Sorafenib

Reactions Weekly, 2021
openaire   +1 more source

Sorafenib

Reactions Weekly, 2015
  +5 more sources

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis

Cell Metabolism, 2020
Zan Huang, Zhi-Gang She, Lihua Zhu
exaly  

New insights on sorafenib resistance in liver cancer with correlation of individualized therapy

Biochimica Et Biophysica Acta: Reviews on Cancer, 2020
Ding Jin
exaly  

ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma

Acta Pharmacologica Sinica, 2020
Guo-Dong Lu, Jing Zhou, Xiao-Wei Huang   +2 more
exaly  

Sorafenib

Reactions Weekly, 2014
openaire   +2 more sources

Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells

Cell Death and Disease, 2013
Cheng A-L, C-Y Liu, Liu C-Y
exaly  

Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial

Journal of Hepatology, 2018
Yi-Hsiang Huang, Weijing Sun, Alessandro Granito   +2 more
exaly  

Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond

Cancer Treatment Reviews, 2018
Jean-Luc Raoul, Peter Robert Galle, Masatoshi Kudo   +2 more
exaly  

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial

European Journal of Cancer, 2012
Won Young Tak, Ann-Lii Cheng, Dimitris Voliotis   +2 more
exaly